Historical record - last NADAC effective date: 1/6/2015
Product Information
ACTOPLUS MET 15 MG-850 MG TAB is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $7.6480 per EA under NDC 64764015818. Its NADAC has been published 69 times since Nov 28, 2013.
FDA first approved this application on Aug 29, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850; 15 mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764015818
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/6/2015
Active Ingredients
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021842FDA Approved
8/29/2005
TE Code
AB
On Market Since
8/29/2005
Pharmacological Classes
Price Statistics
The NADAC for ACTOPLUS MET 15 MG-850 MG TAB has been published 69 times since Nov 28, 2013, and over the history we have for it it has risen 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.6480 per EA |
|---|---|
| All-time high | $7.6480 (Jul 8, 2015) |
| All-time low | $5.7778 (Nov 28, 2013) |
| Median price | $6.9591 |
| Average price | $6.9584 |
| Largest weekly change | +9.9% (Jan 15, 2014) |
| Weeks tracked | 69 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+32.4%
Last surveyed Jul 8, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACTOPLUS MET 15 MG-850 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ACTOPLUS MET 15 MG-850 MG TAB, manufactured by Takeda Pharmaceuticals America, Inc., is $7.6480 per EA (NDC 64764015818), effective Jul 8, 2015.
How has the price of ACTOPLUS MET 15 MG-850 MG TAB changed over time?
Over the history we have for it, the NADAC for ACTOPLUS MET 15 MG-850 MG TAB has risen 32.4%. It has been tracked across 69 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACTOPLUS MET 15 MG-850 MG TAB?
Since Nov 28, 2013, the NADAC for ACTOPLUS MET 15 MG-850 MG TAB has ranged from a low of $5.7778 (Nov 28, 2013) to a high of $7.6480 (Jul 8, 2015), with a median of $6.9591 per EA.
Are there cheaper alternatives to ACTOPLUS MET 15 MG-850 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACTOPLUS MET 15 MG-850 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ACTOPLUS MET 15 MG-850 MG TAB?
ACTOPLUS MET 15 MG-850 MG TAB (NDC 64764015818) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.